News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

AstraZeneca PLC (AZN) Hands Back Several Compounds To Targacept, Inc. (TRGT)


2/11/2014 7:32:59 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Biotech company Targacept Inc (TRGT.O) said British drugmaker AstraZeneca (AZN.L) would return rights to several pre-clinical compounds, sending the U.S. company's shares down 10 percent in extended trading. A licensing agreement, signed in 2005, continues for the remaining compounds, including AZD1446, a potential treatment for Alzheimer's disease.

Help employers find you! Check out all the jobs and post your resume.

Read at Reuters
Read at News Release


comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES